Cargando…
Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy
Systemic administration of immune checkpoint blockade (ICB) monoclonal antibodies (mAbs) can unleash antitumor functions of T cells but is associated with variable response rates and off-target toxicities. We hypothesized that antitumor efficacy of ICB is limited by the minimal accumulation of mAb w...
Autores principales: | Francis, David M., Manspeaker, Margaret P., Schudel, Alex, Sestito, Lauren F., O’Melia, Meghan J., Kissick, Haydn T., Pollack, Brian P., Waller, Edmund K., Thomas, Susan N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377700/ https://www.ncbi.nlm.nih.gov/pubmed/32998971 http://dx.doi.org/10.1126/scitranslmed.aay3575 |
Ejemplares similares
-
Elicitation of stem-like CD8(+) T cell responses via lymph node-targeted chemoimmunotherapy evokes systemic tumor control
por: Manspeaker, Margaret P, et al.
Publicado: (2022) -
Quality of CD8(+) T cell immunity evoked in lymph nodes is compartmentalized by route of antigen transport and functional in tumor context
por: O’Melia, M. J., et al.
Publicado: (2020) -
Thermosensitive hydrogel releasing nitric oxide donor and anti-CTLA-4 micelles for anti-tumor immunotherapy
por: Kim, Jihoon, et al.
Publicado: (2022) -
Lymph node metastases rate of locoregional and non-locoregional lymph node stations in gastric cancer
por: de Jong, Mees Hendrik Siert, et al.
Publicado: (2022) -
Programmable multistage drug delivery to lymph nodes
por: Schudel, Alex, et al.
Publicado: (2020)